---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295685864.md"
description: "Bolt Biotherapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results."
datetime: "2026-08-12T15:17:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295685864.md)
  - [en](https://longbridge.com/en/news/295685864.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295685864.md)
generator: "portal-rs"
---

# 

Bolt Biotherapeutics shares are trading lower after the company reported worse-than-expected Q2 financial results.

### Related Stocks

- [BOLT.US](https://longbridge.com/en/quote/BOLT.US.md)

## Related News & Research

- [Bolt, Stellantis plan autonomous driving experiment in Greater Paris from 2028](https://longbridge.com/en/news/302864321.md)
- [Bolt Biotherapeutics CEO William P. Quinn acquires 637 common shares valued at $2,469.01](https://longbridge.com/en/news/299687685.md)
- [Darling Ingredients (DAR) Could Be 31% Undervalued On Reaffirmed Guidance And Product Launch](https://longbridge.com/en/news/302994330.md)
- [I'd Buy Half a Position in Amazon Stock Before Its Oct. 29 Report -- and Half After](https://longbridge.com/en/news/303054275.md)
- [AppLovin Corporation $APP Stock Purchased by Hedeker Wealth LLC](https://longbridge.com/en/news/303049441.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**